Lau DT - Search Results

1

Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM; Hepatitis B Research Network. Park JJ, et al. Among authors: lau dt. Gastroenterology. 2016 Mar;150(3):684-695.e5. doi: 10.1053/j.gastro.2015.11.050. Epub 2015 Dec 10. Gastroenterology. 2016. PMID: 26684441 Free PMC article.

2

New therapies for chronic hepatitis B.

Hoofnagle JH, Lau D. Hoofnagle JH, et al. J Viral Hepat. 1997;4 Suppl 1:41-50. doi: 10.1111/j.1365-2893.1997.tb00159.x. J Viral Hepat. 1997. PMID: 9097277 Review.

3

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa.

Lau DT, Everhart J, Kleiner DE, Park Y, Vergalla J, Schmid P, Hoofnagle JH. Lau DT, et al. Gastroenterology. 1997 Nov;113(5):1660-7. doi: 10.1053/gast.1997.v113.pm9352870. Gastroenterology. 1997. PMID: 9352870 Clinical Trial.

4

Serum hepatitis G virus RNA in patients with chronic viral hepatitis.

Marrone A, Shih JW, Nakatsuji Y, Alter HJ, Lau D, Vergalla J, Hoofnagle JH. Marrone A, et al. Am J Gastroenterol. 1997 Nov;92(11):1992-6. Am J Gastroenterol. 1997. PMID: 9362178

5

Statistical models for predicting a beneficial response to interferon-alpha in patients with chronic hepatitis B.

Lau DT, Comanor L, Minor JM, Everhart JE, Wuestehube LJ, Hoofnagle JH. Lau DT, et al. J Viral Hepat. 1998 Mar;5(2):105-14. doi: 10.1046/j.1365-2893.1998.00087.x. J Viral Hepat. 1998. PMID: 9572035

6

Lamivudine for chronic delta hepatitis.

Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, Hoofnagle JH. Lau DT, et al. Hepatology. 1999 Aug;30(2):546-9. doi: 10.1002/hep.510300217. Hepatology. 1999. PMID: 10421666 Clinical Trial.

7

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy.

Lau DT, Kleiner DE, Park Y, Di Bisceglie AM, Hoofnagle JH. Lau DT, et al. Gastroenterology. 1999 Nov;117(5):1229-33. doi: 10.1016/s0016-5085(99)70409-9. Gastroenterology. 1999. PMID: 10535887

8

Long-term therapy of chronic hepatitis B with lamivudine.

Lau DT, Khokhar MF, Doo E, Ghany MG, Herion D, Park Y, Kleiner DE, Schmid P, Condreay LD, Gauthier J, Kuhns MC, Liang TJ, Hoofnagle JH. Lau DT, et al. Hepatology. 2000 Oct;32(4 Pt 1):828-34. doi: 10.1053/jhep.2000.17912. Hepatology. 2000. PMID: 11003630

9

A rapid immunochromatographic assay for hepatitis B virus screening.

Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, Woods GL, Park Y, Hoofnagle JH. Lau DT, et al. J Viral Hepat. 2003 Jul;10(4):331-4. doi: 10.1046/j.1365-2893.2003.00418.x. J Viral Hepat. 2003. PMID: 12823602

10

A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.

Gish RG, Lau DT, Schmid P, Perrillo R. Gish RG, et al. Among authors: lau dt. Am J Gastroenterol. 2007 Dec;102(12):2718-23. doi: 10.1111/j.1572-0241.2007.01449.x. Epub 2007 Jul 27. Am J Gastroenterol. 2007. PMID: 17662102 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page